Neuroanatomical hypothesis of panic disorder, revised

American Journal of Psychiatry

Volumn 157, Issue 4, 2000, Pages 493-505

  Gorman, Jack M ^a   Kent, Justine M ^b   Sullivan, Gregory M ^b   Coplan, Jeremy D ^b  

^a Columbia University ^*  (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIOR THERAPY; CONDITIONING; ENVIRONMENTAL FACTOR; FEAR; GENETIC RISK; HUMAN; HYPOTHESIS; NEUROBIOLOGY; NEUROPATHOLOGY; PANIC; PRIORITY JOURNAL; REVIEW; SEROTONIN RELEASE;

ADULT; AMYGDALA; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; BRAIN STEM; COGNITION; COGNITIVE THERAPY; CONDITIONING (PSYCHOLOGY); DISEASE MODELS, ANIMAL; DISEASES IN TWINS; FAMILY; FEAR; HIPPOCAMPUS; HUMANS; LIFE CHANGE EVENTS; MODELS, NEUROLOGICAL; NEURAL PATHWAYS; PANIC DISORDER; PREFRONTAL CORTEX; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; TWIN STUDIES;

EID: 0034066256     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.157.4.493     Document Type: Review

References (103)

1. Gorman JM, Liebowitz MR, Fyer AJ, Stein J: A neuroanatomical hypothesis for panic disorder. Am J Psychiatry 1989; 146: 148-161
2. Kent JM, Coplan JD, Gorman JM: Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety. Biol Psychiatry 1998; 44:812-824
3. Welkowitz LA, Papp LA, Cloitre M, Liebowitz MR, Martin LY, Gorman JM: Cognitive-behavior therapy for panic disorder delivered by psychopharmacologically oriented clinicians. J Nerv Ment Dis 1991; 179:473-477
4. Papp LA, Martinez JM, Klein DF, Coplan JD, Norman RG, Cole R, de Jesus MJ, Ross D, Goetz R, Gorman JM: Respiratory psychophysiology of panic disorder: three respiratory challenges in 98 subjects. Am J Psychiatry 1997; 154:1557-1565
5. Yeragani VK, Pohl R, Berger R, Balon R, Ramesh C, Glitz D, Srinivasan K, Weinberg P: Decreased heart rate variability in panic disorder patients: a study of power-spectral analysis of heart rate. Psychiatry Res 1993; 46:89-103
6. Callahan PM, de la Garza R II, Cunningham KA: Mediation of the discriminative stimulus properties of cocaine by mesocorticolimbic dopamine systems. Pharmacol Biochem Behav 1997; 57:601-607
7. Breiter HC, Gollub RL, Weisskoff RM, Kennedy DN, Makris N, Berke JD, Goodman JM, Kantor HL, Gastfriend DR, Riorden JP, Mathew RT, Rosen BR. Hyman SE: Acute effects of cocaine on human brain activity and emotion. Neuron 1997; 19: 591-611
8. Klein DF: False suffocation alarms, spontaneous panics, and related conditions: an integrative hypothesis. Arch Gen Psychiatry 1993; 50:306-317
9. Pavlov IP: Conditioned Reflexes: An Investigation of the Physiological Activity of the Cerebral Cortex (1927). Edited by Anrep GV. New York, Boyer, 1960
10. LeDoux JE, Cicchetti P, Xagoraris A, Romanski LM: The lateral amygdaloid nucleus: sensory interface of the amygdala in fear conditioning. J Neurosci 1990; 10:1062-1069
11. LeDoux JE, Iwata J, Cicchetti P, Reis DJ: Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J Neurosci 1988; 8: 2517-2519
12. Davis M: The role of the amygdala in fear and anxiety. Annu Rev Neurosci 1992; 15:353-375
13. Takeuchi Y, McLean JH, Hopkins DA: Reciprocal connections between the amygdala and parabrachial nuclei: ultrastructural demonstration by degeneration and axonal transport of horse-radish peroxidase in the cat. Brain Res 1982; 239:583-588
14. Price JL, Amaral DG: An autoradiographic study of the projections of the central nucleus of the monkey amygdala. J Neurosci 1981; 1:1242-1259
15. Cedarbaum JM, Aghajanian GK: Afferent projections to the rat locus coeruleus as determined by a retrograde tracing technique. J Comp Neurol 1978; 178:1-16
16. Dunn JD, Whitener J: Plasma corticosterone responses to electrical stimulation of the amygdaloid complex: cytoarchitectural specificity. Neuroendocrinology 1986; 42:211-217
17. De Oca BM, DeCola JP, Maren S, Fanselow MS: Distinct regions of the periaqueductal gray are involved in the acquisition and expression of defensive responses. J Neurosci 1998; 18:3426-3432
18. de Olmos J: Amygdaloid nuclear gray complex, in The Human Nervous System. Edited by Paxinos G. San Diego, Academic Press, 1990, pp 583-710
19. Freedman RR, Ianni P, Ettedgui E, Puthezhath N: Ambulatory monitoring of panic disorder. Arch Gen Psychiatry 1985; 42: 244-248
20. Martinez JM, Papp LA, Coplan JD, Anderson DE, Mueller CM, Klein DF, Gorman JM: Ambulatory monitoring of respiration in anxiety. Anxiety 1996; 2:296-302
21. Gorman JM, Papp LA, Coplan JD, Martinez JM, Lennon S, Goetz RR, Ross D, Klein DF: Anxiogenic effects of CO2 and hyperventilation in patients with panic disorder. Am J Psychiatry 1994; 151:547-553
22. Papp LA, Klein DF, Gorman JM: Carbon dioxide hypersensitivity, hyperventilation, and panic disorder. Am J Psychiatry 1993; 150:1149-1157
23. Coplan JD, Goetz R, Klein DF, Papp LA, Fyer AJ, Liebowitz MR, Davies SO, Gorman JM: Plasma cortisol concentrations preceding lactate-induced panic: psychological, biochemical, and physiological correlates. Arch Gen Psychiatry 1998; 55: 130-136
24. Woods SW, Charney DS, McPherson CA, Gradman AH, Heninger GR: Situational panic attacks: behavioral, physiologic, and biochemical characterization. Arch Gen Psychiatry 1987; 44:365-375
25. Liebowitz MR, Gorman JM, Fyer AJ, Levitt M, Dillon D, Levy G, Appleby IL, Anderson S, Palij M, Davies SO, Klein DF: Lactate provocation of panic attacks, II: biochemical and physiological findings. Arch Gen Psychiatry 1985; 42:709-719
26. Gorman JM, Fyer MR, Goetz R, Askanazi J, Liebowitz MR, Fyer AJ, Kinney J, Klein DF: Ventilatory physiology of patients with panic disorder. Arch Gen Psychiatry 1988; 45:31-39
27. Charney DS, Heninger GR, Breier A: Noradrenergic function in panic anxiety: effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry 1984; 41:751-763
28. Targum SD, Marshall LE: Fenfluramine provocation of anxiety in patients with panic disorder. Psychiatry Res 1989; 28:295-306
29. Klein E, Zohar J, Geraci MF, Murphy DL, Uhde TW: Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects. Biol Psychiatry 1991; 30:973-984
30. Pyke RE, Greenberg HS: Norepinephrine challenges in panic patients. J Clin Psychopharmacol 1986; 6:279-285
31. Veltman DJ, van Zijderveld GA, van Dyck R: Epinephrine infusions in panic disorder: a double-blind placebo-controlled study. J Affect Disord 1996; 39:133-140
32. Jensen CF, Peskind ER, Veith RC, Hughes J, Cowley DS, Roy-Byrne P, Raskind MA: Hypertonic saline infusion induces panic in patients with panic disorder. Biol Psychiatry 1991; 30: 628-630
33. Bradwejn J, Koszycki D: The cholecystokinin hypothesis of anxiety and panic disorder. Ann NY Acad Sci 1994; 713:273-282
34. American Psychiatric Association: Practice Guideline for the Treatment of Patients With Panic Disorder. Am J Psychiatry 1998; 155(May suppl)
35. Kreiss DS, Lucki I: Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J Pharmacol Exp Ther 1995; 274:866-875
36. Boyer W: Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a metaanalysis. Int Clin Psychopharmacol 1995; 10:45-49
37. Hoyer D, Martin G: 5-HT receptor classification and nomenclature: toward a harmonization with the human genome. Neuropharmacology 1997; 36:419-428
38. Blier P, DeMontigny C, Chaput Y: Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression. J Clin Psychopharmacol 1987; 7:24S-35S
39. Handley SL: 5-Hydroxytryptamine pathways in anxiety and its treatment. Pharmacol Ther 1995; 66:103-148
40. Tork I, Hornung J-P: Raphe nuclei and the serotonergic system, in The Human Nervous System. Edited by Paxinos G. San Diego, Academic Press, 1990, pp 1001-1022
41. Aston-Jones G, Akaoka H, Charlety P, Chouvet G: Serotonin selectively attenuates glutamate-evoked activation of noradrenergic locus coeruleus neurons. J Neurosci 1991; 11:760-769
42. Coplan JD, Papp LA, Pine DS, Martinez JM, Cooper TB, Rosenblum L, Klein DF, Gorman JM: Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder. Arch Gen Psychiatry 1997; 54:643-648
43. Viana MB, Graeft FG, Loschmann PA: Kainate microinjection into the dorsal raphe nucleus induces 5-HT release in the amygdala and periaqueductal gray. Pharmacol Biochem Behav 1997; 58:167-172
44. Deakin JFW, Graeff F: 5-HT and mechanisms of defence. J Psychopharmacol 1991; 5:305-315
45. Brady LS, Gold PW, Herkenham M, Lynn AB, Whitfield HJ Jr: The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications. Brain Res 1992; 572:117-125
46. Elkabir DR, Wyatt ME, Vellucci SV, Herbert J: The effects of separate or combined infusions of corticotrophin-releasing factor and vasopressin either intraventricularly or into the amygdala on aggressive and investigative behaviour in the rat. Regul Pept 1990; 28:199-214
47. Butler PD, Weiss JM, Stout JC, Nemeroff CB: Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J Neurosci 1990; 10:176-183
48. Baram TZ, Mitchell WG, Haden E: Inhibition of pituitary-adrenal secretion by a corticotropin releasing hormone antagonist in humans. Mol Psychiatry 1996; 1:320-324
49. Griebel G, Perrault G, Sanger DJ: Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents: comparison with diazepam and buspirone. Psychopharmacology (Berl) 1988; 138:55-66
50. Stutzmann GE, LeDoux JE: GABAergic antagonists block the inhibitory effects of serotonin in the lateral amygdala: a mechanism for modulation of sensory inputs related to fear conditioning. J Neurosci 1999; 19:RC8
51. Sokoloff L: Relationships among local functional activity, energy metabolism, and blood flow in the central nervous system. Fed Proc 1981; 40:2311-2316
52. Raichle ME, Grubb RL Jr, Gado MH, Eichling JO, Ter-Pogossian MM: Correlation between regional cerebral blood flow and oxidative metabolism. Arch Neurol 1976; 33:523-526
53. Fox PT, Raichle ME: Cerebral blood flow and oxidative metabolism are focally uncoupled by physiological activation: a positron-emission tomographic study, in Cerebrovascular Diseases. Edited by Raichle ME, Powers WJ. New York, Raven Press, 1987, pp 129-138
54. Stewart RS, Devous MD Sr, Rush AJ, Lane L, Bonte FJ: Cerebral blood flow changes during sodium-lactate-induced panic attacks. Am J Psychiatry 1988; 145:442-449
55. Gorman JM, Goetz R, Uy J, Ross D, Martinez J, Fyer AJ, Liebowitz MR, Klein DF: Hyperventilation occurs during lactate-induced panic. J Anxiety Disorders 1988; 2:193-202
56. Ball S, Shekhar A: Basilar artery response to hyperventilation in panic disorder. Am J Psychiatry 1997; 154:1603-1604
57. Dager SR, Strauss WL, Marro KI, Richards TL, Metzger GD, Artru AA: Proton magnetic resonance spectroscopy investigation of hyperventilation in subjects with panic disorder and comparison subjects. Am J Psychiatry 1995; 152:666-672
58. Goddard AW, Gorman JM, Charney DS: Neurobiology of panic disorder, in Panic Disorder and Its Treatment. Edited by Rosenbaum JF, Pollack MH. New York, Marcel Dekker, 1998, pp 57-92
59. Matthews RJ: Sympathetic control of cerebral circulation: relevance to psychiatry. Biol Psychiatry 1995; 37:283-285
60. Kalaria RN, Stockmeier CA, Harik SI: Brain microvessels are innervated by locus ceruleus noradrenergic neurons. Neurosci Lett 1989; 97:203-208
61. Marovitch S, Iadecola C, Ruggiero DA, Reis DJ: Widespread reductions in cerebral blood flow and metabolism elicited by electrical stimulation of the parabrachial nucleus in the rat. Brain Res 1985; 314:283-296
62. Fredrikson M, Wik G, Fischer H, Andersson J: Affective and attentive neural networks in humans: a PET study of Pavlovian conditioning. Neuroreport 1995; 7:97-101
63. Morris J, Frith C, Perret D. Rowland D, Young A, Calder A, Dolan R: A differential neural response in the human amygdala to fearful and happy facial expressions. Nature 1996; 383:812-815
64. Furmark T, Fischer H, Wik G, Larsson M, Fredrikson M: The amygdala and individual differences in human fear conditioning. Neuroreport 1997; 8:3957-3960
65. Hugdahl K, Beraki A, Thompson W, Kosslyn S, Macy R, Baker D, Alpert N, LeDoux JE: Brain mechanisms in human classical conditioning: a PET blood flow study. Neuroreport 1995; 6: 1723-1728
66. LaBar KS, Gatenby JC, Gore JC, LeDoux JE, Phelps EA: Human amygdala activation during conditioned fear acquisition and extinction: a mixed-trial fMRI study. Neuron 1998; 20: 937-945
67. Grodd W, Schneider F, Klose U, Nagele T: [Functional magnetic resonance tomography of psychological functions exemplified by experimentally induced emotions]. Radiologe 1995; 35:283-289 (German)
68. Papp LA, Martinez J, Coplan JD, Gorman JM: Rebreathing tests in panic disorder. Biol Psychiatry 1995; 38:240-245
69. Corfield DR, Fink GR. Ramsay SC. Murphy K, Harty HR, Watson JDG, Adams L, Frackowiak RSJ, Guz A: Activation of limbic structures during C02-stimulated breathing in awake man, in Modeling and Control of Ventilation. Edited by Semple SJG, Adams L, Whipp BJ. New York. Plenum, 1995, pp 331-334
70. Flint J, Corley R, DeFries JC. Fulker DW. Gray JA, Miller S, Collins AC: A simple genetic basis for a complex psychological trait in laboratory mice. Science 1995; 269:1432-1435
71. Wehner JM, Radcliffer RA, Rosmann ST, Christensen SC, Rasmussen DL, Fulker DW, Wiles M: Quantitative trait locus analysis of contextual fear conditioning in mice. Nat Genet 1997; 17:331-334
72. Caldarone B, Saavedra C. Tartaglia K, Wehner JM, Dudek BC, Flaherty L: Quantitative trait loci analysis affecting contextual conditioning in mice. Nat Genet 1997; 17:335-337
73. Flint J: Freeze! Nat Genet 1997; 17:250-251
74. Weissman MM, Wickramaratne P, Adams PB, Lish JD, Horwath E, Charney D, Woods SW, Leeman E, Frosch E: The relationship between panic disorder and major depression: a new family study. Arch Gen Psychiatry 1993; 50:767-780
75. Togersen S: Genetic factors in anxiety disorders. Arch Gen Psychiatry 1983; 40:1085-1089
76. Kendler KS, Neale MC. Kessler RC, Heath AC, Eaves LJ: Panic disorder in women: a population-based twin study Psychol Med 1993; 23:397-406
77. Skre I, Onstad S. Togersen S, Lygren S, Kringlen E: A twin study of DSM-III-R anxiety disorders. Acta Psychiatr Scand 1993; 88:85-92
78. Kagan J, Reznick JS, Snidman N: The physiology and psychology of behavioral inhibition. Child Dev 1987; 58:1459-1473
79. Pine DS, Cohen P, Gurley D, Brook J, Ma Y: The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. Arch Gen Psychiatry 1998; 55:56-64
80. Tweed JL, Schoenbach VJ, George LK, Blazer DG: The effects of childhood parental death and divorce on six-month history of anxiety disorders. Br J Psychiatry 1989; 154:823-828
81. Stein MB, Walker JR. Anderson G, Hazen AL, Ross CA, Eldridge G, Forde DR: Childhood physical and sexual abuse in patients with anxiety disorders and in a community sample. Am J Psychiatry 1996; 153:275-277
82. Carter MM, Hollon SD, Carson R, Shelton RC: Effects of a safe person on induced distress following a biological challenge in panic disorder with agoraphobia. J Abnorm Psychol 1995; 104:156-163
83. Papp LA, Welkowitz LA, Martinez JM, Klein DF, Browne S, Gorman JM: Instructional set does not alter outcome of respiratory challenges in panic disorder. Biol Psychiatry 1995; 38: 826-830
84. Francis DD, Meaney MJ: Maternal care and the development of stress responses. Curr Opin Neurobiol 1999; 9:128-134
85. Anisman H, Zaharia MD, Meaney MJ, Merali Z: Do early-life events permanently alter behavioral and hormonal responses to stressors? Int J Dev Neurosci 1998; 16:149-164
86. Caldji C, Tannenbaum B, Sharma S, Francis D, Plotsky PM, Meaney JM: Maternal care during infancy regulates the development of neural systems mediating the expression of fearfulness in the rat. Proc Natl Acad Sci USA 1998; 95:5335-5340
87. Liu D, Diorio J, Tannenbaum B, Caldji C, Francis D, Freedman A, Sharma S, Pearson D, Plotsky PM, Meaney JM: Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science 1997; 277:1659-1662
88. Andrews MW, Rosenblum LA: The development of affiliative and agonistic social patterns in differentially reared monkeys. Child Dev 1994; 65:1398-1404
89. Coplan JD, Andrews MW, Rosenblum LA, Owens MJ, Gorman JM, Nemeroff CB: Increased cerebrospinal fluid CRF concentration in adult non-human primates previously exposed to adverse experiences as infants. Proc Natl Acad Sci USA 1996; 93:1619-1623
90. Rosenblum LA, Coplan JD, Friedman S, Bassoff TB, Gorman JM: Adverse early experiences affect noradrenergic and serotonergic functioning in adult primates Biol Psychiatry 1994; 35:221-227
91. Tweed JL, Schoenbach VJ, George LK, Blazer DG: The effects of childhood parental death and divorce on six-month history of anxiety disorders. Br J Psychiatry 1989; 154:823-828
92. Faravelli C, Webb T, Ambonetti A, Fonnesu F, Sessarego A: Prevalence of traumatic early life events in 31 agoraphobic patients with panic attacks. Am J Psychiatry 1985; 142:1493-1494
93. Faravelli C, Pallanti S: Recent life events and panic disorder. Am J Psychiatry 1989; 146:622-626
94. Horesh N, Amir M, Kedem P, Goldberger Y, Kotler M: Life events in childhood, adolescence and adulthood and the relationship to panic disorder. Acta Psychiatr Scand 1997; 96: 373-378
95. Shear MK, Masur JD: Standardized assessment for panic disorder research: a conference report. Arch Gen Psychiatry 1994; 51:346-354
96. Phillips RG, LeDoux JE: Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci 1992; 106:274-285
97. Kim JJ, Fanselow MS: Modality-specific retrograde amnesia of fear. Science 1992; 256:675-677
98. Barlow DH: Cognitive-behavioral therapy for panic disorder: current status. J Clin Psychiatry 1997; 58(suppl 2):32-36
99. Hibbert GA: Ideational components of anxiety: their origin and content. Br J Psychiatry 1984; 144:618-624
100. Klerman GL: Depression and panic anxiety: the effect of depressive comorbidity on response to drug treatment of patients with panic disorder and agoraphobia. J Psychiatr Res 1990; 24(suppl 2):27-41
101. Markowitz JS, Weissman MM, Ouellette R, Lish JD, Klerman GL: Quality of life in panic disorder. Arch Gen Psychiatry 1989; 46:984-992
102. LeDoux JE: The Emotional Brain: The Mysterious Underpinnings of Emotional Life. New York, Simon & Schuster, 1996
103. Otto MW, Whittal ML: Cognitive-behavior therapy and the longitudinal course of panic disorder. Psychiatr Clin North Am 1995; 18:803-820